beta
Trial Radar AI

Showing clinical trials for Type 2 Diabetes Mellitus.

I can help you find nearby clinical trials and understand health conditions and treatments.
94 Results
Top 50 Showing
 
Status (Default)
Not yet Recruiting, Recruiting, Active, Not Recruiting
×
 
Condition
Type 2 Diabetes Mellitus
×
 
Intervention
GLP-1
×
 
Type
Drug
×
 
Study Title
Status
GLP-1 and Hypoglycemia NCT01858896
Active, not recruiting
Dietary Insights and Nutrition Experiences in Adults on GLP-1 Therapy - A Study on Diet Quality Changes in Adults on GLP-1 Therapy (DINE-GLP1) NCT07313384
Recruiting
Beta Cell Function in Type 2 Diabetes: Differential Effects of SGLT2 Inhibitors and GLIP-Receptor Agonists NCT07325435
Active, not recruiting
Investigating the Impact of GLP-1 RA Therapy on Osteosarcopenia in Older Female Adults With Diabetes (GLOW) NCT07428746
Not yet recruiting
Association of Gene Polymorphism With Susceptibility to T2DM and the Therapeutic Responses to Exenatide in Chinese Patients With T2DM NCT06256419
Recruiting
Insulin-Mediated Glucose Uptake and Organ Perfusion Assessed by Total-Body PET During GIP and GLP-1 Infusion NCT07398300
Recruiting
Improving Cardiovascular Disease Diagnosis and Treatment in Kazakhstan Using Metabolic Correction With GLP-1 Drugs (ICDDTKZ26) NCT07303556
Active, not recruiting
GLP1-RAs Effects on Inflammatory and Endothelial Biomarkers in T2DM (STABLE-GLP1) NCT07314684
Recruiting
PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes (PRECIDENTD) NCT05390892
Recruiting
A Study to Evaluate the Efficacy and Safety of Once-Weekly MET097 in Adults With Obesity or Overweight and T2DM (VESPER-2) NCT06897202
Active, not recruiting
Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study (CER-4-T2D) NCT05220917
Active, not recruiting
Comparative Effectiveness of Empagliflozin in the US NCT03363464
Active, not recruiting
Efficacy and Safety of iGlarLixi Versus Standard of Care in a Real-world Adult China Population With Uncontrolled Type 2 Diabetes on Oral Agents NCT07307235
Not yet recruiting
Menopausal Hormone Therapy, GLP-1 Agonists, and Glucose and Energy Homeostasis in Postmenopausal Women With Diabetes (DECLARED-CT) NCT06715514
Recruiting
The Effect of Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in People With Type 1 and Type 2 Diabetes NCT06976619
Recruiting
Efficacy and Safety of the Met+SGLT-2i+GLP-1RA in Patients With Type 2 Diabetes With Poor Glycemic Control (MESSAGE) NCT07244003
Recruiting
A Trial to Evaluate Safety, Feasibility and Efficacy of the ReCET Procedure (EMINENT-2) NCT05984238
Active, not recruiting
Efficacy, Safety and Tolerability of AZD6234 in Participants Living With Overweight or Obesity With Type 2 Diabetes Who Are on a Stable Dose of GLP-1 Receptor Agonist (ARAY) NCT06851858
Active, not recruiting
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy NCT07502508
Recruiting
A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs (EXCEED) NCT05663515
Recruiting
Current Status of Islet Alpha Cell Function in Patients with Type 2 Diabetes NCT06825182
Recruiting
Impact of Pharmacogenetic-Guided Treatment on Type 2 Diabetes. (EPHIC-DIA2) NCT06851962
Active, not recruiting
Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes NCT06706284
Recruiting
iGlarLixi CGM Study in Chinese T2D Individuals After OADs (China Soli-CGM) NCT06671587
Recruiting
A Study to Compare the Efficacy and Safety of GZR102 Injection and GZR18 Injection in Type 2 Diabetes Mellitus NCT07055386
Active, not recruiting
Heterogeneity of Diabetes: Integrated Muli-Omics to Identify Physiologic Subphenotypes and Evaluate Targeted Prevention NCT06682351
Not yet recruiting
Surgical or Medical Treatment (ST2OMP) NCT04128995
Active, not recruiting
A Study to Investigate Safety and Efficacy of iGlarLixi in Adult Patients With Type 2 Diabetes Mellitus NCT06716424
Active, not recruiting
Pharmacogenetics of Response to GLP1R Agonists (PORT) NCT05071898
Recruiting
GLP-1/GCG Dual Agonist in Type 2 Diabetes With Early Dementia (LIGHT-COG Study) NCT07083154
Recruiting
Efficacy and Safety of GZR18 Every 2 Weeks Versus Tirzepatide and Placebo in Obese or Overweight Participants NCT06737042
Not yet recruiting
Real-World Evaluation of Omarigliptin for Type 2 Diabetes Meliitus in Bangladesh NCT06449235
Not yet recruiting
LIGHT-MCI Trial: GLP-1 Agonist, SGLT2 Inhibitor, and DPP-4 Inhibitor for MCI Remission in Type 2 Diabetes NCT05313529
Active, not recruiting
VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2) NCT07104383
Recruiting
Effects of Semaglutide on Clinical Outcomes and Metabolic Inflammation in Psoriasis (SEMAPSO) NCT07401992
Recruiting
Study to Evaluate HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus NCT07193459
Recruiting
Rebalancing the Fat Content of the Heart and Muscles (Re-CHARM) NCT07065383
Not yet recruiting
Safety, Tolerability and Preliminary Efficacy of Sublingual Liraglutide in Patients With Type 2 Diabetes Mellitus NCT05268237
Recruiting
A Phase 3 Study to Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus NCT07082114
Recruiting
Transformative Research in Diabetic Nephropathy 2.0 (TRIDENT 2) NCT07444203
Recruiting
Liraglutide Treatment in Patients With Maturity-onset Diabetes of the Young (MODY) NCT07029009
Recruiting
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both (REIMAGINE 5) NCT06534411
Active, not recruiting
HbA1c Variability in Type II Diabetes NCT02879409
Active, not recruiting
The Ameliorative Effects of GLP-1RA on Diabetic Cardiac Autonomatic Neuropathy NCT06461377
Recruiting
Clinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1RA in CKD (ADIPO-CKD) NCT07309094
Recruiting
Effects of Tirzepatide and Insulin Glargine on Glucolipid Metabolism and Brain Function in Patients With Type 2 Diabetes NCT05553093
Recruiting
Glucagon-like-peptide-1 Receptor Agonists in Patients Receiving Maintenance Dialysis (GUARD-1) NCT07017270
Not yet recruiting
GLUCOSE-MGH: Genetic Links Understood Through Challenge With Oral Semaglutide Exposure at MGH NCT06003153
Recruiting
Chronic Dorzagliatin on Insulin and Incretin Function in Intermediate Hyperglycemia and Type 2 Diabetes NCT06671340
Not yet recruiting
GLP-1Ra Impact on Metabolic Outcomes in Stage 2 T1DM While Receiving Teplizumab (GLP-TEP) NCT06338553
Recruiting